Law360, New York (October 13, 2011, 5:33 PM EDT) -- A federal judge on Wednesday substantially trimmed an employee whistleblower suit that claims units of Solvay SA and Abbott Laboratories defrauded federal and state government health care programs by bribing doctors to prescribe their drugs Luvox, Aceon and AndroGel and promote their off-label uses.
In a 138-page opinion, U.S. District Judge Gray H. Miller of the Southern District of Texas dismissed federal False Act Claim violation claims alleging Solvay America Inc. and Solvay Pharmaceuticals Inc. — which Abbott bought in 2009 for $6.6 billion — offered kickbacks to doctors who prescribed the drugs, manipulated Medicare, Medicaid and other government health care...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!